Shilpa Pharma

Global CDMO Services in Germany by India’s Trusted Partner​

CMO contract manufacturing Organization -Shilpa Pharma

Shilpa Pharma proudly delivers world-class CDMO services to Germany, supporting pharmaceutical and biotech innovators with high-quality, compliant, and scalable manufacturing solutions. As a globally trusted contract development and manufacturing organization, we combine European-quality standards, cutting-edge technology, and deep scientific expertise to help German companies accelerate their pipeline from development to commercial success.

With global regulatory approvals including USFDA, EU GMP, PMDA, ANVISA, COFEPRIS, KFDA, and TGA, Shilpa Pharma is recognized for its strong quality systems, unmatched technical capabilities, and proven track record in regulated markets. Our advanced facilities specialize in oncology, high-potency APIs, complex generics, specialty therapeutics, biologics, and end-to-end formulation development—all backed by strict confidentiality and reliable supply performance.

Whether you are seeking cost-effective large-scale manufacturing, high-potency handling expertise, or a trusted CDMO partner for advanced formulations, Shilpa Pharma delivers solutions engineered for the German pharmaceutical market. We focus on precision, compliance, innovation, and on-time delivery, making us the preferred choice for companies looking for dependable CDMO services in Germany.

Partner with Shilpa Pharma—where world-class science meets world-class manufacturing to support Germany’s dynamic pharmaceutical and biotech landscape.

Fully Accredited, Fully Compliant Facilities

COFEPRIS CERTIFIED
ANVISA CERTIFIED
PMDA certified
US FDA APPROVED

Contact for End-to-End CDMO Services in Germany

From route scouting to GMP manufacturing, Shilpa Pharma is your trusted CDMO company in India. Reach out today and let’s bring your drug development goals to life.

Request a Quote for CDMO Services

Complex Chemistry? Consider It Done.

From simple to multi-step syntheses, we deliver precision-built CDMO solutions tailored to your needs.

Advanced Chemistry, Backed by Innovation

Expertise in solid and solution-phase synthesis, cryogenic, and high-pressure reactions.

Flexible, Scalable & Globally Compliant

Offering non-GMP to GMP manufacturing — from lab-scale to commercial production.

Our Expertise at a Glance

Leading the Way in Pharma Innovation

Global CMO Contract Manufacturing Partner in Germany

product manufacturing

Quality & Compliance : The Foundation of Every Partnership

At Shilpa Pharma, quality isn’t just a process — it’s a promise. We adhere to the highest international regulatory standards, ensuring that every product manufactured under our name meets the strictest benchmarks for safety, efficacy, and consistency. Our manufacturing facilities are fully compliant with cGMP, EMA, WHO, and USFDA guidelines, supported by rigorous internal audits and continuous improvement programs.

We maintain end-to-end traceability, validated systems, and robust quality control mechanisms throughout development, production, and packaging. From raw material sourcing to final product release, every stage is governed by precision, transparency, and accountability. This unwavering focus on compliance enables us to deliver products that not only meet regulatory expectations but also exceed client trust — making Shilpa Pharma a preferred CDMO partner in Germany and across the globe.

global accreditations

Serving Clients Across The Globe

End-to-End CDMO Services in Germany by Shilpa Pharma

At Shilpa Pharma, we deliver world-class Contract Development and Manufacturing Organization (CDMO) services to pharmaceutical and biotechnology companies in Germany. As a trusted global CDMO partner, we help accelerate product development, ensure regulatory compliance, and optimize manufacturing efficiency. With our proven expertise in drug substance manufacturing, formulation development, and large-scale production, we bring your innovations to life with precision and reliability.

Whether you require end-to-end CDMO services in Germany or specialized CDMO biologics solutions, Shilpa Pharma offers flexible, scalable, and cost-effective options tailored to your specific development and commercial goals.

What is CDMO?

A Contract Development and Manufacturing Organization (CDMO) provides integrated drug development and manufacturing services to pharmaceutical and biotech firms. From formulation design and clinical trial material production to full-scale commercial manufacturing, CDMOs handle the complete product lifecycle. This partnership enables companies to focus on innovation, research, and patient care, while leveraging expert technical capabilities and global compliance support.

Why Pharmaceutical Companies Choose Shilpa Pharma for CDMO Services in Germany

Global pharmaceutical firms partner with Shilpa Pharma for our seamless blend of Indian manufacturing excellence and European quality standards. Our reputation as a leading global CDMO is built on innovation, compliance, and client trust.

Here’s why companies in Germany choose Shilpa Pharma:

    • High-Quality Standards: We meet global regulatory norms including EU GMP, USFDA, and WHO compliance.

    • Cost Efficiency: Competitive pricing without compromising technology or product integrity.

    • Skilled Scientific Expertise: A dedicated team of experienced scientists, chemists, and engineers with global project experience.

    • Regulatory Strength: Proven track record with multiple international approvals and audits.

    • End-to-End Capabilities: From R&D and formulation to packaging and logistics — we cover it all under one roof.

Advantages of Our CDMO Services in Germany

Partnering with Shilpa Pharma for CDMO solutions delivers clear advantages:

  • Accelerated Time-to-Market: Streamlined development processes for faster launches.

  • Scalability: Flexible capacity for both small-batch and commercial-scale production.

  • Regulatory Expertise: In-depth understanding of EMA and global compliance standards.

  • Innovation & R&D Support: Access to advanced laboratories and formulation technologies.

  • Reduced Risk: Shared technical, operational, and compliance responsibility.

Global Regulatory Approvals and Compliance

As a globally recognized CDMO in India, Shilpa Pharma’s manufacturing facilities meet the highest international quality standards. Our plants hold multiple global certifications and approvals that reflect our dedication to excellence and compliance.

Our facilities are:

  • USFDA Approved (United States Food & Drug Administration)

  • EU GMP Certified (European Union Good Manufacturing Practice)

  • ANVISA Approved (Brazilian Health Regulatory Agency)

  • COFEPRIS Approved (Mexico)

  • TGA Certified (Australia)

  • PMDA Approved (Japan)

  • KFDA Certified (South Korea)

These certifications position Shilpa Pharma as a trusted CDMO pharma company for both regulated and semi-regulated markets around the world.

Why Choose Shilpa Pharma for CDMO in India?

Ranked among the top global CDMO companies, Shilpa Pharma is recognized for its innovation-driven approach, uncompromised quality, and transparent partnerships.

Our Key Strengths:

    • Comprehensive Expertise: From formulation to final product, we deliver complete CDMO solutions.

    • Advanced Infrastructure: Equipped with state-of-the-art technology and GMP-compliant facilities.

    • Global Reach: Serving pharmaceutical companies across Europe, Japan, China, and other markets.

    • Quality Commitment: Adherence to global compliance and best manufacturing practices.

    • Collaborative Partnership: We value transparency, flexibility, and on-time delivery.

Trusted by Global Markets

Our commitment to excellence, reliability, and innovation has made Shilpa Pharma the preferred CDMO services provider for companies across Germany, Europe, Japan, and beyond. We take pride in our ability to bridge global standards with cost-effective, efficient solutions — helping clients achieve success in competitive pharmaceutical markets.

Let’s Connect!

Get our capability overview via email